Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death

dc.contributor.authorDizaji, Babak Faraji
dc.contributor.authorAzerbaijan, Mohammadreza Hasani
dc.contributor.authorSheisi, Niloofar
dc.contributor.authorGoleij, Pouya
dc.contributor.authorMirmajidi, Tahereh
dc.contributor.authorChogan, Faraz
dc.contributor.authorSharafian, Fariborz
dc.date.accessioned2026-02-06T18:38:14Z
dc.date.issued2020
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractIn the present study, the various zeolites including hydrophilic Y zeolite, hydrophobic ZSM-5 zeolite and metal organic frameworks (MOFs) including MIL-101 and ZIF-8 were incorporated into the PLGA/chitosan nanofibers for controlled release of Paclitaxel anticancer drug against prostate cancer in vitro and in vivo. The synthesized nanoparticles and nanofibers were characterized using FTIR, XRD, SEM, BET and water contact angle analysis. The drug loading efficiency of nanofibers containing zeolites and MOFs indicated that the MOFs were more useful compared with zeolites for higher loading of Paclitaxel molecules. The Paclitaxel release behavior from nanofibers containing zeolites and MOFs were also examined. The MTT assay and DAPI staining analysis were used to determine the cytotoxicity and apoptosis effect of nanofibers containing Paclitaxel against LNCaP prostate cancer cell lines. The tumor inhibition rate in vivo was carried out to obtain the optimum nanofibrous formulation with maximum cell death percentage and tumor inhibition rate. The obtained results revealed the better activity of MOFs compared nanozeolites for higher loading of Paclitaxel drug into the nanoparticles and a more sustained release of drug from nanofibers containing MOFs. (C) 2020 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.ijbiomac.2020.07.228
dc.identifier.endpage1474
dc.identifier.issn0141-8130
dc.identifier.issn1879-0003
dc.identifier.orcid0000-0001-8410-8868
dc.identifier.orcid0000-0002-5328-5420
dc.identifier.orcid0000-0003-4135-7594
dc.identifier.orcid0000-0002-6180-8412
dc.identifier.orcid0000-0002-2213-497X
dc.identifier.pmid32735933
dc.identifier.scopus2-s2.0-85089465588
dc.identifier.scopusqualityQ1
dc.identifier.startpage1461
dc.identifier.urihttps://doi.org/10.1016/j.ijbiomac.2020.07.228
dc.identifier.urihttps://hdl.handle.net/11129/12839
dc.identifier.volume164
dc.identifier.wosWOS:000588093700134
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofInternational Journal of Biological Macromolecules
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectPLGA/chitosan nanofibers
dc.subjectZeolite
dc.subjectMetal organic framework
dc.subjectPaclitaxel
dc.subjectProstate cancer
dc.titleSynthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death
dc.typeArticle

Files